| abstract |
The present invention provides combined therapy methods for treating a proliferative disease (such as cancer) comprising a first therapy comprising administration to a patient, of an effective amount of taxane in a nanoparticle composition and a second therapy that may include administration of an effective amount of at least one additional agent that modifies the epigenetics in a cell. |